ProCE Banner Activity

COVID-19 in Immunocompromised Patients: Vaccine Responsiveness and the Potential for SARS-CoV-2 Variants in Patients With Prolonged Infection

Clinical Thought
Navigating what is currently known about responsiveness to COVID-19 vaccines and the potential for SARS-CoV-2 variants in immunocompromised patients.

Released: June 28, 2021

Expiration: June 27, 2022

No longer available for credit.


Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Gilead Sciences, Inc.